← Open Payments lookup

LAUREN CIESLAK: Open Payments

NPI 1770198137 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$591 in 29 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $423 · 2025 $591

Food & beverage: $591
CompanyPaymentsAmount
GENZYME CORPORATION9$195
GlaxoSmithKline, LLC.6$103
Insmed, Inc.4$77
Boehringer Ingelheim Pharmaceuticals, Inc.3$58
Verona Pharma, Inc.2$46
Viatris Specialty LLC1$30
Actelion Pharmaceuticals US, Inc.1$26
Grifols USA, LLC1$23
Regeneron Healthcare Solutions, Inc.1$20
AstraZeneca Pharmaceuticals LP1$15

Products named: DUPIXENT, NUCALA, Arikayce, Ohtuvayre, OFEV, YUPELRI, OPSUMIT, Prolastin-C Liquid.

Industry payments across MI — which companies pay providers there.